摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Benzo(b)thiophene, ethyl- | 54385-63-6

中文名称
——
中文别名
——
英文名称
Benzo(b)thiophene, ethyl-
英文别名
6-ethyl-1-benzothiophene
Benzo(b)thiophene, ethyl-化学式
CAS
54385-63-6
化学式
C10H10S
mdl
——
分子量
162.25
InChiKey
XPDFLCCDJKRYRT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    11
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    28.2
  • 氢给体数:
    0
  • 氢受体数:
    1

反应信息

  • 作为产物:
    描述:
    6-vinylbenzo[b]thiophene 在 nickel(II) chloride hexahydrate 、 三乙醇胺 、 tetrabutylammonium tetrafluoroborate 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 生成 Benzo(b)thiophene, ethyl-
    参考文献:
    名称:
    电化学镍催化加氢
    摘要:
    描述了一种经济有效的电化学镍催化烯烃加氢反应。该反应具有出色的底物通用性和官能团兼容性以及独特的化学选择性。值得注意的是,烷基溴和芳基溴的加氢脱溴可以使用相同的反应体系和不同的配体来实现,并且通过配体的选择可以实现烯烃加氢和加氢脱溴之间的高化学选择性。
    DOI:
    10.1002/anie.202403475
点击查看最新优质反应信息

文献信息

  • POLYMERIZABLE MONOMER, POLYMER COMPOUND FOR CONDUCTIVE POLYMER, AND METHOD FOR PRODUCING THE POLYMER COMPOUND
    申请人:SHIN-ETSU CHEMICAL CO., LTD.
    公开号:US20200247926A1
    公开(公告)日:2020-08-06
    Polymerization reaction is performed using a polymerizable monomer shown by the following general formula (1) and at least one monomer selected from monomers each having a structure of a salt among a lithium salt, a sodium salt, a potassium salt, and a nitrogen compound salt of a fluorosulfonic acid or the like; then, the structure of the salt of the repeating unit of a polymer obtained by the polymerization reaction is changed to the fluorosulfonic acid or the like by ion exchange. Thus, the present invention provides a polymer compound for a conductive polymer and a method for producing the polymer compound which is suitably used as a dopant for a fuel cell and a conductive material, and which is a copolymer containing a repeating unit of styrene having a 3,3,3-trifluoro-2-hydroxy-2-trifluoromethylisobutyl ether group, and a repeating unit having any of a fluorosulfonic acid, a fluorosulfonimide group, and a n-carbonyl-fluoro-sulfonamide group.
    聚合反应使用以下一般式(1)所示的可聚合单体和至少一种选择自锂盐、钠盐、钾盐和氟磺酸盐等盐结构的单体中的单体进行;然后,通过离子交换将聚合反应得到的聚合物的重复单元的盐结构改变为氟磺酸盐或类似物。因此,本发明提供了一种用作导电聚合物的聚合物化合物以及用作燃料电池和导电材料的掺杂剂的聚合物化合物的生产方法,该聚合物是含有3,3,3-三氟-2-羟基-2-三氟甲基异丁基醚基的苯乙烯重复单元和具有氟磺酸、氟磺酰亚胺基团和n-羰基-氟磺酰胺基团中的任何一种的重复单元的共聚物。
  • Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof
    申请人:Unoki Gen
    公开号:US20070072898A1
    公开(公告)日:2007-03-29
    A pyrazolo[1,5-a]pyridine derivative represented by formula (I) and salt thereof exhibit excellent MAPKAP-K2 inhibitory activity. Accordingly, medicines comprising this compound as an active ingredient are expected to be valuable for treating or preventing diseases mediated by MAPKAP-K2 such as inflammatory injury, autoimmune diseases, asteropathia destruens, cancer and/or growth of tumor.
    由式(I)表示的吡唑并[1,5-a]吡啶衍生物及其盐表现出优异的MAPKAP-K2抑制活性。因此,包含该化合物作为活性成分的药物预计对治疗或预防由MAPKAP-K2介导的疾病,如炎症损伤、自身免疫疾病、asteropathia destruens、癌症和/或肿瘤生长具有重要价值。
  • Intracellular Kinase Inhibitors
    申请人:Flynn A. Gary
    公开号:US20070293499A1
    公开(公告)日:2007-12-20
    Intracellular kinase inhibitors and their therapeutic uses for patients with T cell malignancies, B cell malignancies, autoimmune disorders, and transplanted organs.
    细胞内激酶抑制剂及其在T细胞恶性肿瘤、B细胞恶性肿瘤、自身免疫性疾病和移植器官患者中的治疗用途。
  • Composition containing carbon nanotubes having coating thereof and process for producing them
    申请人:Saitoh Takashi
    公开号:US20060052509A1
    公开(公告)日:2006-03-09
    The object of the present invention is to provide a carbon nanotube composition that does not impair the characteristics of the carbon nanotubes itself, allows the carbon nanotubes to be dispersed or solubilized in a solvent, does not cause separation or aggregation of the carbon nanotubes even during long-term storage, has superior electrical conductivity, film formability and moldability, can be easily coated or covered onto a base material, and the resulting coated film has superior moisture resistance, weather resistance and hardness; a composite having a coated film composed thereof; and, their production methods. In order to achieve this object, the present invention provides a carbon nanotube composition that contains a conducting polymer (a) or heterocyclic compound trimer (i), a solvent (b) and carbon nanotubes (c), and may additionally contain a high molecular weight compound (d), a basic compound (e), a surfactant (f), a silane coupling agent (g) and colloidal silica (h) as necessary; a composite having a coated film composed of the composition; and, their production methods.
    本发明的目的是提供一种碳纳米管组合物,不会影响碳纳米管本身的特性,使碳纳米管可以分散或溶解在溶剂中,在长期储存期间不会导致碳纳米管分离或聚集,具有优异的电导性、成膜性和成型性,可以轻松地涂覆或覆盖在基材上,所得到的涂层膜具有优异的防潮性、耐候性和硬度;一种由涂层膜组成的复合材料;以及它们的生产方法。为了实现这一目的,本发明提供了一种碳纳米管组合物,其中包含导电聚合物(a)或杂环化合物三聚体(i)、溶剂(b)和碳纳米管(c),并可根据需要另外包含高分子量化合物(d)、碱性化合物(e)、表面活性剂(f)、硅烷偶联剂(g)和胶体二氧化硅(h);一种由该组合物组成的涂层膜复合材料;以及它们的生产方法。
  • Novel compounds
    申请人:Nomura Sumihiro
    公开号:US20050233988A1
    公开(公告)日:2005-10-20
    A compound of the formula: wherein Ring A and Ring B are: (1) Ring A is an optionally substituted unsaturated monocyclic heterocyclic ring, and Ring B is an optionally substituted unsaturated monocyclic heterocyclic ring, an optionally substituted unsaturated fused heterobicyclic ring, or an optionally substituted benzene ring, (2) Ring A is an optionally substituted benzene ring, and Ring B is an optionally substituted unsaturated monocyclic heterocyclic ring or an optionally substituted unsaturated fused heterobicyclic ring, or (3) Ring A is an optionally substituted unsaturated fused heterobicyclic ring, and Ring B are independently an optionally substituted unsaturated monocyclic heterocyclic ring, an optionally substituted unsaturated fused heterobicyclic ring, or an optionally substituted benzene ring; X is a carbon atom or a nitrogen atom; Y is —(CH 2 ) n — (n is 1 or 2); a pharmaceutically acceptable salt thereof, or a prodrug thereof.
    一种化合物,其化学式为:其中环A和环B分别为:(1)环A为可选取代的不饱和单环杂环,环B为可选取代的不饱和单环杂环、可选取代的不饱和融合杂双环或可选取代的苯环;(2)环A为可选取代的苯环,环B为可选取代的不饱和单环杂环或可选取代的不饱和融合杂双环;或(3)环A为可选取代的不饱和融合杂双环,环B独立地为可选取代的不饱和单环杂环、可选取代的不饱和融合杂双环或可选取代的苯环;X为碳原子或氮原子;Y为—(CH2)n—(n为1或2);其药学上可接受的盐或其前药。
查看更多

同类化合物